Get startedLog in
    Picture of Theriva Biologics logo

    TOVX — Theriva Biologics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Theriva Biologics Announces First Patient Dosed In VIRAGE

    Picture of Theriva Biologics logoTheriva Biologics
    17/01/2023 14:55
    Jan 17 (Reuters) - Theriva Biologics Inc  TOVX.A :
    * THERIVA BIOLOGICS ANNOUNCES FIRST PATIENT DOSED IN VIRAGE,
A
PHASE 2B TRIAL OF SYSTEMICALLY ADMINISTERED VCN-01 IN
COMBINATION WITH CHEMOTHERAPY IN PANCREATIC DUCTAL
ADENOCARCINOMA

Source text for Eikon:  ID:nGNX846NZ3 
Further company coverage:  TOVX.A

    Recent news on Theriva Biologics

    See all news